Skip to main content
Search
Explore journals
Get published
About BMC
My account
Search all BMC articles
Search
Journal of Hematology & Oncology
Home
About
Articles
Submission Guidelines
Submit manuscript
Article metrics
Last updated: Fri, 29 Mar 2024 6:12:35 Z
Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma